Search

Nafeeza Hafeez

from Brookline, MA
Age ~53
Get Report
Also known as:
Bibi N Hafeez, Nafeeza L Monteiro, Bibinafeeza Hafeez
Phone and address:
231 Saint Paul St, Brookline, MA 02446
(617) 232-1140
Related to:
Muhammad Qasim, 83
Connected to:
Amna E Hafeez, 50Anusha Hafeez, 28Bibi S Hafeez, 49Faris Hafeez, 38Hanan HafeezHussain Hafeez, 42Kassam Hafeez, 41Lyla Hafeez, 45Mariam S Hafeez, 54Naveed Hafeez, 58

Nafeeza Hafeez Phones & Addresses

  • 231 Saint Paul St, Brookline, MA 02446 (617) 232-1140
  • 231 Saint Paul St APT 5, Brookline, MA 02446 (617) 232-1140
  • 285 Tappan St, Brookline, MA 02445
  • 134 Wren St, West Roxbury, MA 02132 (617) 325-2795
  • Richmond Hill, NY
  • Arlington, MA
  • New York, NY
  • Marlborough, MA

Work

Company: Ksq therapeutics, inc. Oct 2019 Position: Principal scientist

Education

School / High School: City University of New York

Industries

Pharmaceuticals

Resumes

Resumes

Nafeeza Hafeez Photo 1

Principal Scientist

View page
Location:
Boston, MA
Industry:
Pharmaceuticals
Work:
Ksq Therapeutics, Inc.
Principal Scientist
Ksq Therapeutics, Inc. May 2018 - Sep 2019
Associate Principal Scientist
Novartis Institutes For Biomedical Research (Nibr) 2015 - 2018
Scientific Technical Leader
Novartis Institutes For Biomedical Research (Nibr) 2013 - 2015
Senior Scientist
Ipi 2009 - 2012
Scientist
Education:
City University of New York
Hunter College

Publications

Us Patents

Compounds And Methods For Inhibiting The Interaction Of Bcl Proteins With Binding Partners

View page
US Patent:
20060025460, Feb 2, 2006
Filed:
Jun 17, 2005
Appl. No.:
11/156364
Inventors:
Alfredo Castro - Winchester MA, US
Wei Deng - Lexington MA, US
Kristopher Depew - Acton MA, US
Michael Foley - Chestnut Hill MA, US
Christian Fritz - Natick MA, US
Asimina Georges Evangelinos - Andover MA, US
Michael Grogan - Arlington MA, US
Nafeeza Hafeez - West Roxbury MA, US
Edward Holson - Newton Highlands MA, US
Brian Hopkins - Brookline MA, US
Nii Koney - Somerville MA, US
Tao Liu - Ashland MA, US
David Mann - Swampscott MA, US
Lisa Marcaurelle - Arlington MA, US
Daniel Snyder - Cambridge MA, US
Dennis Underwood - Jamaica Plain MA, US
Andrew Wylie - Brookline MA, US
Lin-Chen Yu - Wollaston MA, US
Linping Zhang - Lexington MA, US
Assignee:
Infinity Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07D 261/02
A61K 31/42
US Classification:
514378000, 548240000
Abstract:
One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer.

Pharmaceutical Combinations

View page
US Patent:
20180064709, Mar 8, 2018
Filed:
Mar 23, 2016
Appl. No.:
15/561209
Inventors:
Nicole Buschmann - Basel, CH
Robin Alec Fairhurst - Basel, CH
Jorge Garcia Fortanet - Wilmington MA, US
Pascal Furet - Thann, FR
Diana Graus Porta - Basel, CH
Nafeeza Hafeez - Brookline MA, US
Bo Han - Shanghai, CN
Thomas Knoepfel - Rheinfelden, CH
Matthew J. LaMarche - Reading MA, US
Catherine Leblanc - Basel, CH
International Classification:
A61K 31/496
A61K 31/497
Abstract:
A pharmaceutical combination comprising N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide, or a pharmaceutically acceptable salt thereof, and at least one active ingredient, as defined herein, or a pharmaceutically acceptable salt thereof, and optionally a pharmaceutically acceptable carrier, for simultaneous or sequential administration; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.

Therapeutic Combination For The Treatment Of Cancer

View page
US Patent:
20170304313, Oct 26, 2017
Filed:
Oct 2, 2015
Appl. No.:
15/517035
Inventors:
- Basel, CH
Nafeeza Hafeez - Cambridge MA, US
International Classification:
A61K 31/55
A61K 31/496
A61K 31/506
A61K 45/06
Abstract:
This invention relates to a pharmaceutical combination comprising (a) an EGFR inhibitor and (b) a FGFR inhibitor, particularly for use in the treatment of a cancer. This invention also relates to uses of such combination for preparation of a medicament for the treatment of a cancer; methods of treating or preventing a cancer in a subject in need thereof comprising administering to said subject a jointly therapeutically effective amount of said combination; pharmaceutical compositions comprising such combination and commercial packages thereto.
Control profile
Nafeeza Hafeez from Brookline, MA, age ~53 Get Report